Hyaluronic acid in the enhancement of lens regeneration

• US 20060083732A1
• Filed: 12/01/2005
• Published: 04/20/2006
• Est. Priority Date: 06/30/2004
• Status: Abandoned Application

• Current Assignee: Abbott Medical Optics Incorporated (Johnson & Johnson)
• Original Assignee: Abbott Medical Optics Incorporated (Johnson & Johnson)
• Inventors: Gwon, Arlene
• Application Number:
  US11/293,682
• Publication Number:
  US 20060083732A1
• Time in Patent Office: Days
• US Class Current: 424/94.610
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/728 Hyaluronic acid
• CPC Class Codes: A61K 38/39 Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
• CPC Class Codes: A61K 38/47 acting on glycosyl compounds (3.2), e.g. cellulases, lactases
• CPC Class Codes: A61L 2430/16 for reconstruction of eye parts, e.g. intraocular lens, cornea
• CPC Class Codes: A61P 27/02 Ophthalmic agents

Abstract

The present invention addresses the treatment of ocular conditions by the enhancement of lens regeneration. This is accomplished by the administration of a high viscosity composition including a hyaluronic acid compound. Excess high viscosity composition may be removed by focal laser photophacoablation or through the use of a digestive compound or enzyme such as hyaluronidase. Additionally, a collagen product may be injected within the lens capsule to improve lens cell proliferation and differentiation, and to improve the configuration, shape and structure of regenerated lenses. Various embodiments involving the enhancement of lens regeneration are described. For example, lens regeneration may be enhanced by filling the lens capsule bag with the inventive hyaluronic acid compound; by inserting at least one collagen patch in the lens capsule; and/or by injecting a collagen-based product into the lens capsule.

Claims

1. A method for enhancing regeneration of lens cells in a mammal, comprising:

filling a lens capsule bag of said mammal with a composition comprising hyaluronic acid, and

after formation of a ring of lens tissue, administering hyaluronidase into the capsular bag.

2. The method of claim 1, further comprising:

inserting at least one collagen patch in said lens capsule bag.

3. The method of claim 1, wherein said composition is selected from the group consisting of Restylane®

, Perlane®

, and combinations thereof.

4. The method of claim 1, wherein said hyaluronic acid compound is present in said composition at a concentration of at least about 20 mg/ml.

5. The method of claim 1, further comprising:

phacoemulsifying a lens contained in said lens capsule bag prior to said inserting of said at least one collagen patch.

6. The method of claim 1, wherein the hyaluronidase is administered between 1 week and 6 months after the filling of the capsule bag.

7. A method for treating an ocular condition, comprising:

providing a first composition comprising hyaluronic acid;

inserting said first composition into a lens capsule bag to enhance regeneration of lens cells, thereby treating said ocular condition; and

after formation of a ring of lens tissue, inserting a second composition into the lens capsule bag to dissolve the first composition.

8. The method of claim 7, further comprising:

inserting a collagen patch into said lens capsule bag.

9. The method of claim 7, wherein said first composition comprises hyaluronic acid at a concentration of at least about 20 mg/ml.

10. The method of claim 7, wherein said first composition comprises a crosslinked hyaluronic acid.

11. The method of claim 7, wherein the second composition comprises hyaluronidase.

12. The method of claim 7, wherein said ocular condition is a cataract.

13. The method of claim 7, wherein the hyaluronidase is administered between 1 week and 6 months after the inserting of the first composition into the capsule bag.

14. A method for enhancing regeneration of lens cells in a mammal, comprising:

providing a polymeric composition;

filling a lens capsule bag of said mammal with said composition, and

administering an enzymatic compound into the lens capsule bag.

15. The method of claim 14, wherein the polymeric compound is hyaluronic acid.

16. The method of claim 14, wherein the enzymatic compound is hyaluronidase.

17. A method for enhancing regeneration of lens cells in a mammal, comprising:

filling a lens capsule bag of said mammal with a composition comprising hyaluronic acid,

waiting a period of time sufficient for formation of a ring of lens tissue; and

administering hyaluronidase into the capsular bag.

18. The method of claim 17, further comprising:

inserting a collagen patch into said lens capsule bag.

19. The method of claim 17, wherein said first composition comprises hyaluronic acid.

20. The method of claim 17, wherein said first composition comprises a cross-linked hyaluronic acid.

21. The method of claim 17, wherein the second composition comprises hyaluronidase.

22. The method of claim 17, wherein the waiting period is less than 6 months.

23. The method of claim 17, wherein the waiting period is between 1 week and 6 months.